GE Healthcare's biopharmaceutical factory KUBio is the first modular facility to manufacture monoclonal antibodies. The 1,200 m2 facility uses GE Healthcare's Ready-to-Process single-use technologies and the company claims total planning, delivery and construction can be achieved in 14–18 months.
Rights and permissions
About this article
Cite this article
Monoclonals Lego factory. Nat Biotechnol 30, 903 (2012). https://doi.org/10.1038/nbt1012-903a
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1012-903a